| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 09/06/2002 | WO2002067858A2 Novel treatment of neurodegenerative diseases by altering levels of trkb isoforms and/or trkc isoforms |
| 09/06/2002 | WO2002067857A2 Modified annexin proteins and methods for preventing thrombosis |
| 09/06/2002 | WO2002067848A2 PEPTIDES FROM THE 16/6id ANTIBODY FOR TREATING SLE |
| 09/06/2002 | WO2002067760A2 Methods for treating autoimmune diseases in a subject and in vitro diagnostic assays |
| 09/06/2002 | WO2002057225A3 Thrombin inhibitors |
| 09/06/2002 | WO2002055018A3 Inhibiting gs-fdh to modulate no bioactivity |
| 09/06/2002 | WO2002053092A3 Methods employing and compositions containing plaque associated molecules for prevention and treatment of atherosclerosis |
| 09/06/2002 | WO2002051449A3 Composition and process for bone growth and repair |
| 09/06/2002 | WO2002048182A3 Interferon-alpha induced gene |
| 09/06/2002 | WO2002047712A3 Peptide yy and peptide yy agonists for treatment of metabolic disorders |
| 09/06/2002 | WO2002046415A9 Polynucleotide and polypeptide sequences of putative transporters and ion channells |
| 09/06/2002 | WO2002043654A3 Pharmaceutical composition and method for treatment of brain injury, spinal cord injury, stroke, neurodegenerative disease and other conditions |
| 09/06/2002 | WO2002042425A3 Antisense modulation of mp-1 expression |
| 09/06/2002 | WO2002040517A3 M. tuberculosis chaperonin 60.1 and uses thereof |
| 09/06/2002 | WO2002040037A3 M. tuberculosis chaperonin 60.1 and uses thereof |
| 09/06/2002 | WO2002039121A3 Methods for detecting the efficacy of anticancer treatments |
| 09/06/2002 | WO2002036809A3 Antisense modulation of sr-cyp expression |
| 09/06/2002 | WO2002036771A3 Imaging, diagnosis and treatment of disease |
| 09/06/2002 | WO2002023995A8 Method of blocking free radical processes which result in media ted pathology without deleterious pro-oxidant side reactions |
| 09/06/2002 | WO2002016574A3 Method for identifying peptides that can be specifically cleaved and the use of peptide sequences of this type |
| 09/06/2002 | WO2002010217A3 Endothelial cell expression patterns |
| 09/06/2002 | WO2002000879A3 Methods for producing modified glycoproteins |
| 09/06/2002 | WO2002000687A3 Antimicrobial peptides and methods of use thereof |
| 09/06/2002 | WO2001095946A3 Combination product for carrying out a cytotoxic treatment in a mammal |
| 09/06/2002 | WO2001094612A3 Method for identifying medically valuable active substances |
| 09/06/2002 | WO2001092523A3 Human polynucleotides and polypeptides encoded thereby |
| 09/06/2002 | WO2001091805A3 Compounds for targeting endothelial cells |
| 09/06/2002 | WO2001085785A3 Ph domain-interacting protein |
| 09/06/2002 | WO2001082910A3 Combination of progesterone and mifepristone for cancer therapy |
| 09/06/2002 | WO2001079287A3 Steatosis-modulating factors and uses thereof |
| 09/06/2002 | WO2001079276A3 Leishmania antigens for use in the therapy and diagnosis of leishmaniasis |
| 09/06/2002 | WO2001079270A3 Migraine and vasodilation treatment |
| 09/06/2002 | WO2001075068A9 Secreted proteins and polynucleotides encoding them |
| 09/06/2002 | WO2001073093A3 Cell-specific adenovirus vectors comprising an internal ribosome entry site |
| 09/06/2002 | WO2001072822B1 Genes involved in intestinal inflammatory diseases and use thereof |
| 09/06/2002 | WO2001070203A3 Agent for treating hepatitis c containing ukrain |
| 09/06/2002 | WO2001064738A3 Heparin-binding amino acid sequences derived from human proteins facilitating penetration of a substance of interest into cells and/or cell nuclei |
| 09/06/2002 | WO2001058915A8 Human g-protein chemokine receptor (ccr5) hdgnr10 |
| 09/06/2002 | WO2001048485A9 Selecting library members capable of binding to epitopes |
| 09/06/2002 | WO2001046253A9 A new polypeptide-calcitonin 11 and the polynucleotide encoding it |
| 09/06/2002 | WO2001032614A9 Novel genes tzap7/a, tzap7/b and tzap7 involved in t cell activation and uses thereof |
| 09/06/2002 | WO2001032195A9 Dietary anti-adiposity food supplements and drugs based on thyrotropin-releasing hormone (trh) |
| 09/06/2002 | WO2001031021A9 Multiple sclerosis-related superantigen |
| 09/06/2002 | WO2001018546A9 Screening for inhibitors of 'paired helical filaments' |
| 09/06/2002 | WO2001018035A9 Muc-1 derived peptides |
| 09/06/2002 | WO2001014581A9 Hdac4 and hdac5 in the regulation of cardiac gene expression |
| 09/06/2002 | WO2001013937A9 Peptides capable of modulating the function of cd66 (ceacam) family members |
| 09/06/2002 | WO2001012236A9 Methods, compositions and kits for promoting recovery from damage to the central nervous system |
| 09/06/2002 | WO2001007627A9 Drosophila recombination-associated protein and methods for use |
| 09/06/2002 | WO2001007059A9 Matrix-targeted fusion polypeptides for tissue regeneration and wound healing |
| 09/06/2002 | WO2000078955A9 Epithelial cell growth inhibitors |
| 09/06/2002 | WO2000067761A9 Compositions and methods for identifying antigens which elicit an immune response |
| 09/06/2002 | CA2756609A1 Use of defibrinated blood for manufacture of a hemoglobin-based oxygen carrier |
| 09/06/2002 | CA2674673A1 Modified and stabilized gdf propeptides and uses thereof |
| 09/06/2002 | CA2439631A1 Method of treating rhinitis or sinusitis |
| 09/06/2002 | CA2439529A1 Proteins and nucleic acids encoding same |
| 09/06/2002 | CA2439472A1 Methods and compositions for modifying apolipoprotein b mrna editing |
| 09/06/2002 | CA2439442A1 Isolated human protease proteins, nucleic acid molecules encoding human protease proteins, and uses thereof |
| 09/06/2002 | CA2439335A1 Interferon regulatory factor-1/human estrogen receptor fusion protein and its use for treating carcinomas |
| 09/06/2002 | CA2439303A1 Methods for identifying peptides which modulate a biological process |
| 09/06/2002 | CA2439297A1 Compositions and methods for protecting tissues and cells from damage, and for repairing damaged tissues |
| 09/06/2002 | CA2439283A1 Isolated human enzyme proteins, nucleic acid molecules encoding human enzyme proteins, and uses thereof |
| 09/06/2002 | CA2439168A1 Modified thrombopoietin with reduced immunogenicity |
| 09/06/2002 | CA2439116A1 Method of improving the growth performance of an animal |
| 09/06/2002 | CA2439100A1 Eye drop |
| 09/06/2002 | CA2438943A1 Hin-1, a tumor suppressor gene |
| 09/06/2002 | CA2438934A1 Chondrogenic potential of human bone marrow-derived cd105+ cells by bmp |
| 09/06/2002 | CA2438923A1 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
| 09/06/2002 | CA2438899A1 Method for determining efficacy of reverse cholesterol transport enhancing agents |
| 09/06/2002 | CA2438886A1 Fusion protein for the secretion of a protein of interest into the supernatant of the bacterial culture |
| 09/06/2002 | CA2438784A1 Compositions and methods for enhancing drug delivery across and into ocular tissues |
| 09/06/2002 | CA2438761A1 Method for treating von willebrand's disease |
| 09/06/2002 | CA2438710A1 <i>nomuraeae rileyi</i>-origin ecdysteroid 22-oxidase and molt hormone inactivation system with the use of the same |
| 09/06/2002 | CA2438696A1 Polynucleotide formulation for enhanced intracellular transfer |
| 09/06/2002 | CA2438652A1 Method for identification of t-cell epitopes and use for preparing molecules with reeduced immunogenicity |
| 09/06/2002 | CA2438273A1 Tryptophanyl-trna synthetase derived polypeptides useful for the regulation of angiogenesis |
| 09/06/2002 | CA2438268A1 Modulation of release from dry powder formulations |
| 09/06/2002 | CA2438238A1 Composition comprising il-22 inhibitors and use thereof for treating inflammatory disorders |
| 09/06/2002 | CA2437898A1 Interferon-alpha induced gene |
| 09/06/2002 | CA2437530A1 Symbiotic regenerative agent |
| 09/06/2002 | CA2437516A1 Heterocarpine, a human ghrh-binding protein |
| 09/06/2002 | CA2437218A1 Modified and stabilized gdf propeptides and uses thereof |
| 09/06/2002 | CA2435815A1 Pharmaceutical composition which comprise a solid dispersion of a hydroxypropylmethylcellulose phthalate polymer |
| 09/06/2002 | CA2434690A1 Proteins, polynucleotides encoding them and methods of using the same |
| 09/06/2002 | CA2433776A1 The use of antigestagens for inhibiting accelerated endometrial maturation during infertility treatment |
| 09/06/2002 | CA2433469A1 83 human secreted proteins |
| 09/06/2002 | CA2432029A1 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
| 09/06/2002 | CA2430702A1 Recombinant poxvirus for chimeric proteins of the human immunodeficiency virus |
| 09/05/2002 | US20020124272 Diploid animal cell for use in the treatment of drug addiction, epilepsey, withdrawal syndrome and muscle spasm |
| 09/05/2002 | US20020123619 Nucleotide sequences coding polypeptide for use in the diagnosis, prevention and treatment of cancer |
| 09/05/2002 | US20020123618 Nucleotide sequences coding polypeptide for use in the diagnosis, prevention and treatment of autoimmune, thyroid and grave's disease |
| 09/05/2002 | US20020123617 Novel immunoglobulin superfamily members of APEX-1, APEX-2 and APEX-3 and uses thereof |
| 09/05/2002 | US20020123614 Modified polypeptides stabilized in a desired conformation and methods for producing same |
| 09/05/2002 | US20020123613 Protein for use in the treatment and diagnosis of cell differentiation and cell maintainance defects |
| 09/05/2002 | US20020123611 Membrane polypeptides for use in treatment of kidney defects |
| 09/05/2002 | US20020123522 Inhibition of inflammation using interleukin-1beta-converting enzyme (ICE)/CED-3 family inhibitors |
| 09/05/2002 | US20020123521 Such as triiodothyroacetic acid, triiodopropionic acid, 4-(2,6-dibromo-4-(1H-tetrazol-5-ylmethyl)-phenoxy)-2-isopropyl-phenol, and 4-(4-hydroxymethyl-2,6-diiodophenoxy)-2-iodo-phenol |
| 09/05/2002 | US20020123510 Administering an NR2B subtype selective N-methyl-D-aspartate (NMDA) receptor antagonist with a thrombolytic agent for treating hypoxic or ischemic stroke |
| 09/05/2002 | US20020123507 Bicyclic derivatives |
| 09/05/2002 | US20020123498 For inhibiting transport protein; therapy |